MALO

Study Details

Full Title

N1T-MC-MALO : A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants with Metabolic Dysfunction-Associated Steatotic Liver Disease who are at Increased Risk of Developing Major Adverse Liver Outcomes (SYNERGY-Outcomes); N1T-MC-TZ01; N1T-MC-RT01

Principal Investigator

Anastasia
Alexopoulos

Protocol Number

PRO00119396

NCT ID

NCT07165028

Phase

III

Enrollment Status

Open to Enrollment